EcoDrugPlus

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSXMAG00000007895
Gene Symbol: SCN8A
4 Cross references
215 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSXMAG00000017742
Gene Symbol: LOC102235665
3 Cross references
205 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSXMAG00000003695
Gene Symbol: LOC102226207
3 Cross references
239 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSXMAG00000030103
Gene Symbol: LOC102227885
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSXMAG00000025904
Gene Symbol: LOC102238020
3 Cross references
239 Possible Orthologues:

Sodium/glucose Cotransporter 2

Ensembl ID : ENSXMAG00000002639
Gene Symbol: LOC102218546
3 Cross references
198 Possible Orthologues:

Sodium/hydrogen Exchanger 3-Like

Ensembl ID : ENSXMAG00000007197
Gene Symbol: LOC102221613
3 Cross references
234 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSXMAG00000013209
Gene Symbol: LOC102217063
2 Cross references
215 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2

Ensembl ID : ENSXMAG00000005698
Gene Symbol: LOC102222505
3 Cross references
205 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2

Ensembl ID : ENSXMAG00000011811
Gene Symbol: LOC102224746
3 Cross references
203 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSXMAG00000027546
Gene Symbol: LOC102231613
3 Cross references
220 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSXMAG00000013010
Gene Symbol: LOC102238368
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).